Chinese Journal of Dermatology ›› 2019, Vol. 52 ›› Issue (7): 445-449.doi: 10.3760/cma.j.issn.0412-4030.2019.07.001
• Expert Commentary • Next Articles
Li Yumei, Zhang Yixuan, Liu Liping
Received:
2018-09-20
Revised:
2018-12-28
Online:
2019-07-15
Published:
2019-07-01
Contact:
Li Yumei
E-mail:yumeili@ujs.edu.cn
Supported by:
CLC Number:
Li Yumei, Zhang Yixuan, Liu Liping. Induced pluripotent stem cells: advances in research and application in dermatology[J].Chinese Journal of Dermatology, 2019, 52(7): 445-449.
[1] | Takahashi K, Yamanaka S. A decade of transcription factor⁃mediated reprogramming to pluripotency[J]. Nat Rev Mol Cell Biol, 2016,17(3):183⁃193. doi: 10.1038/nrm.2016.8. |
[2] | Brix J, Zhou Y, Luo Y. The epigenetic reprogramming roadmap in generation of iPSCs from somatic cells[J]. J Genet Genomics, 2015,42(12):661⁃670. doi: 10.1016/j.jgg.2015.10.001. |
[3] | Teshigawara R, Cho J, Kameda M, et al. Mechanism of human somatic reprogramming to iPS cell[J]. Lab Invest, 2017,97(10):1152⁃1157. doi: 10.1038/labinvest.2017.56. |
[4] | Nishiguchi M, Kikuyama H, Kanazawa T, et al. Increases in iPS transcription factor (Oct4, Sox2, c⁃Myc, and Klf4) gene after modified electroconvulsive therapy[J]. Psychiatry Investig, 2015,12(4):532⁃537. doi: 10.4306/pi.2015. 12.4.532. |
[5] | Yang F, Wang N, Wang Y, et al. Activin⁃SMAD signaling is required for maintenance of porcine iPS cell self⁃renewal through upregulation of NANOG and OCT4 [J]. J Cell Physiol, 2017,232(8):2253⁃2262. doi: 10.1002/jcp.25747. |
[6] | Hoang P, Wang J, Conklin BR, et al. Generation of spatial⁃patterned early⁃developing cardiac organoids using human pluripotent stem cells[J]. Nat Protoc, 2018,13(4):723⁃737. doi: 10.1038/nprot.2018.006. |
[7] | Osaki T, SGM U, Kamm RD. Microphysiological 3D model of amyotrophic lateral sclerosis (ALS) from human iPS⁃derived muscle cells and optogenetic motor neurons[J]. Sci Adv, 2018,4(10):eaat5847. doi: 10.1126/sciadv.aat5847. |
[8] | Ishida Y, Kawakami H, Kitajima H, et al. Vulnerability of Purkinje cells generated from spinocerebellar ataxia type 6 patient⁃derived iPSCs[J]. Cell Rep, 2016,17(6):1482⁃1490. doi: 10.1016/j.celrep.2016.10.026. |
[9] | Mandai M, Watanabe A, Kurimoto Y, et al. Autologous induced stem⁃cell⁃derived retinal cells for macular degeneration[J]. N Engl J Med, 2017,376(11):1038⁃1046. doi: 10.1056/NEJMoa 1608368. |
[10] | Gledhill K, Guo Z, Umegaki⁃Arao N, et al. Melanin transfer in human 3D skin equivalents generated exclusively from induced pluripotent stem cells[J/OL]. PLoS One, 2015,10(8):e0136713. [2018⁃08⁃03]. https://journals.plos.org/plosone/article?id=10.1371/ journal.pone.0136713. doi: 10.1371/journal.pone.0136713. |
[11] | Yang R, Zheng Y, Burrows M, et al. Generation of folliculogenic human epithelial stem cells from induced pluripotent stem cells[J]. Nat Commun, 2014,5:3071. doi: 10.1038/ncomms4071. |
[12] | Kim Y, Park N, Rim YA, et al. Establishment of a complex skin structure via layered co⁃culture of keratinocytes and fibroblasts derived from induced pluripotent stem cells[J]. Stem Cell Res Ther, 2018,9(1):217. doi: 10.1186/s13287⁃018⁃0958⁃2. |
[13] | Umegaki⁃Arao N, Pasmooij AM, Itoh M, et al. Induced pluripotent stem cells from human revertant keratinocytes for the treatment of epidermolysis bullosa[J]. Sci Transl Med, 2014,6(264):264ra164. doi: 10.1126/scitranslmed.3009342. |
[14] | Koehler KR, Hashino E. 3D mouse embryonic stem cell culture for generating inner ear organoids[J]. Nat Protoc, 2014,9(6):1229⁃1244. doi: 10.1038/nprot.2014.100. |
[15] | Lee J, Böscke R, Tang PC, et al. Hair follicle development in mouse pluripotent stem cell⁃derived skin organoids[J]. Cell Rep, 2018,22(1):242⁃254. doi: 10.1016/j.celrep.2017.12.007. |
[16] | Takagi R, Ishimaru J, Sugawara A, et al. Bioengineering a 3D integumentary organ system from iPS cells using an in vivo transplantation model[J]. Sci Adv, 2016,2(4):e1500887. doi: 10.1126/sciadv.1500887. |
[17] | Itoh M, Umegaki⁃Arao N, Guo Z, et al. Generation of 3D skin equivalents fully reconstituted from human induced pluripotent stem cells (iPSCs)[J/OL]. PLoS One, 2013,8(10):e77673. [2018⁃08⁃03]. https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0077673. doi: 10. 1371/journal.pone.0077673. |
[18] | Matsumura W, Fujita Y, Nakayama C, et al. Establishment of integration⁃free induced pluripotent stem cells from human recessive dystrophic epidermolysis bullosa keratinocytes[J]. J Dermatol Sci, 2018,89(3):263⁃271. doi: 10.1016/j.jdermsci.2017. 11.017. |
[19] | Shalom⁃Feuerstein R, Serror L, Aberdam E, et al. Impaired epithelial differentiation of induced pluripotent stem cells from ectodermal dysplasia⁃related patients is rescued by the small compound APR⁃246/PRIMA⁃1MET[J]. Proc Natl Acad Sci U S A, 2013,110(6):2152⁃2156. doi: 10.1073/pnas.1201753109. |
[20] | El⁃Darouti M, Fawzy M, Amin I, et al. Treatment of dystrophic epidermolysis bullosa with bone marrow non⁃hematopoeitic stem cells: a randomized controlled trial[J]. Dermatol Ther, 2016,29(2):96⁃100. doi: 10.1111/dth.12305. |
[21] | Iinuma S, Aikawa E, Tamai K, et al. Transplanted bone marrow⁃derived circulating PDGFRα+ cells restore type Ⅶ collagen in recessive dystrophic epidermolysis bullosa mouse skin graft[J]. J Immunol, 2015,194(4):1996⁃2003. doi: 10.4049/jimmunol. 1400914. |
[22] | Nakayama C, Fujita Y, Matsumura W, et al. The development of induced pluripotent stem cell⁃derived mesenchymal stem/stromal cells from normal human and RDEB epidermal keratinocytes[J]. J Dermatol Sci, 2018,91(3):301⁃310. doi: 10. 1016/j.jdermsci.2018.06.004. |
[23] | Tolar J, McGrath JA, Xia L, et al. Patient⁃specific naturally gene⁃reverted induced pluripotent stem cells in recessive dystrophic epidermolysis bullosa[J]. J Invest Dermatol, 2014,134(5):1246⁃1254. doi: 10.1038/jid.2013.523. |
[24] | Wenzel D, Bayerl J, Nyström A, et al. Genetically corrected iPSCs as cell therapy for recessive dystrophic epidermolysis bullosa[J]. Sci Transl Med, 2014,6(264):264ra165. doi: 10.1126/ scitranslmed.3010083. |
[25] | Sebastiano V, Zhen HH, Haddad B, et al. Human COL7A1⁃corrected induced pluripotent stem cells for the treatment of recessive dystrophic epidermolysis bullosa[J]. Sci Transl Med, 2014,6(264):264ra163. doi: 10.1126/scitranslmed.3009540. |
[26] | Shinkuma S, Guo Z, Christiano AM. Site⁃specific genome editing for correction of induced pluripotent stem cells derived from dominant dystrophic epidermolysis bullosa[J]. Proc Natl Acad Sci U S A, 2016,113(20):5676⁃5681. doi: 10.1073/pnas.15120 28113. |
[27] | Nguyen HV, Li Y, Tsang SH. Patient⁃specific iPSC⁃derived RPE for modeling of retinal diseases[J]. J Clin Med, 2015,4(4):567⁃578. doi: 10.3390/jcm4040567. |
[1] | Xiao Yi, Chen Liping, Jing Danrong, Su Juan, Li Meng, Shen Minxue, Chen Xiang. Application and significance of willingness-to-pay in measuring the burden of skin diseases [J]. Chinese Journal of Dermatology, 2019, 52(4): 286-289. |
[2] | Tang Shunli, Fang Hong. Pathogenesis of androgenetic alopecia [J]. Chinese Journal of Dermatology, 2019, 52(3): 208-210. |
[3] | Qian Yuetong, Liu Jiawei, Liu Wei, Ma Donglai. Radiotherapy-related skin diseases [J]. Chinese Journal of Dermatology, 2019, 52(2): 145-148. |
[4] | Shao Yixin, Wang Duoqin, Shen Yanyun, Zhu Yiqi, Xu Jinhua, Tang Hui. Cultivation and identification of mouse peritoneal and bone marrow-derived mast cells [J]. Chinese Journal of Dermatology, 2018, 51(8): 575-579. |
[5] | . Pain management in photodynamic therapy [J]. Chinese Journal of Dermatology, 2016, 49(9): 676-679. |
[6] | . Update on the diagnosis and treatment of inherited epidermolysis bullosa [J]. Chinese Journal of Dermatology, 2016, 49(7): 516-519. |
[7] | . Clinical application of an improved method of continuous intradermal suture in dermatologic surgery [J]. Chinese Journal of Dermatology, 2014, 47(12): 889-891. |
[8] | . Diagnosis and treatment of dermatoses based on the classification of their etiology, pathogenesis and syndrome: a three-step theory [J]. Chinese Journal of Dermatology, 2010, 43(9): 665-666. |
[9] | QIU Hui, ZHANG Gui-mei, ZHANG Hui, GENG Hui, FENG Zuo-hua. Inhibitory effect on pulmonary metastasis of melanoma in mice by soluble PD-1 and its combina-tion with HspT0-B16 antigen peptides [J]. Chinese Journal of Dermatology, 2007, 40(11): 663-666. |
[10] | XU Wei, ZHAO Jun-ying, ZHAO Hui, GU Fei, HUANG Xiao-ming. Follicular Occlusion Triad:a Case Report and Pedigree Analysis [J]. Chinese Journal of Dermatology, 2005, 38(3): 157-159. |
[11] | XIAO Sheng-xiang, REN Xiao-rong, FENG Yi-guo, WANG Wen-qiang, LIU An, PAN Min. Keratin 17 Gene Mutation in a Pedigree with Pachyonychia Congenita typeⅡ [J]. Chinese Journal of Dermatology, 2003, 36(2): 65-66. |
[12] | ZHANG Ya-qin, LI Ping, Gao Xing-hua, WANG Ya-kun, ZHAO Yu-ming, HE Chun-di, CHEN Hong-duo. Distribution of Haptoglobin Phenotypes in Five Skin Diseases and Their Clinical Significance [J]. Chinese Journal of Dermatology, 2003, 36(10): 562-564. |
[13] | YANG Manli, ZHANG Xingshu. Clinical Analysis of Relationship Between Sjögren’s Syndrome and Other Associated Skin Diseases [J]. Chinese Journal of Dermatology, 2002, 35(6): 464-466. |
[14] | XIONG Lin, RAN Yuping, ZHOU Guangping. Study on Taxonomy of the Genus Malassezia and the Distribution of it in Some Dermatoses [J]. Chinese Journal of Dermatology, 2000, 33(5): 318-320. |
[15] | Wang Qianqiu, Zhang Chuanfu, Xue Huazhong. The Venereal and Nonvenereal Lesions on Penis [J]. Chinese Journal of Dermatology, 1995, 28(3): 150-152. |
|